How to Find Corporate Buyers for Your Patented Technology: The Complete Out-Licensing Framework
Every year, global patent offices issue hundreds of thousands of utility patents to independent inventors, research universities, venture-backed startups, and enterprise R&D departments. Yet, industry data reveals a sobering commercial reality: over 95% of all issued patents never generate a single dollar in commercial revenue or licensing royalties.
For most patent owners, the failure to monetize is not caused by weak technical claims or lack of novelty. It is caused by a flawed go-to-market approach.
Patent holders routinely spend tens of thousands of dollars prosecuting legal claims with patent attorneys, only to treat commercial out-licensing as an afterthought — blasting cold emails with dense legal claim charts to corporate information inboxes or waiting passively for corporate scouts to stumble across their USPTO filings.
In the corporate world, technology acquisition is governed by disciplined financial models, internal R&D roadmaps, risk-adjusted hurdle rates, and strict legal protocols designed to reject unsolicited legal threats.
To successfully out-license or sell your patented technology to an enterprise buyer, you must transition from thinking like a legal claimant to executing like a strategic B2B enterprise dealmaker.
Key Takeaway: Finding corporate buyers for patented technology requires translating legal patent claims into quantifiable business advantages: unit cost reductions, accelerated time-to-market, energy efficiency gains, and regulatory de-risking. By deploying structured non-confidential teasers, leveraging forward-citation intelligence, and utilizing centralized, zero-commission IP marketplaces like GoGetLicense, patent holders can transform dormant IP into lucrative, multi-year commercial licensing streams.
This masterclass guide provides an end-to-end operational blueprint for corporate out-licensors, patent attorneys, academic researchers, and startup executives.
We will explore how corporate technology scouting teams evaluate external IP, how to construct an irresistible non-confidential marketing teaser, how to pinpoint motivated corporate acquirers using patent citation networks, how to negotiate high-value term sheets, and how to execute a 90-day out-licensing campaign.
1. The Out-Licensing Reality Check: Why Traditional Outreach Fails
1.1 The Patent Graveyard: Prosecution vs. Commercialization
A patent is a negative legal right: it grants the owner the legal power to exclude others from making, using, selling, or importing an invention.
It does not, by itself, validate customer demand, manufacturing feasibility, unit economics, or market adoption.
The Patent Monetization Trap
Inventor spends $25K–$100K on legal work
↓
Patent office grants monopoly rights
↓
Patent becomes a legal asset
↓
Cold outreach to corporate legal inboxes
↓
Email ignored or deleted
The Strategic Out-Licensing Funnel
Patent holder quantifies commercial ROI and TRL
↓
Citation analysis identifies potential buyers
↓
Corporate R&D roadmaps are analyzed
↓
Technology is presented through a structured marketplace
↓
Direct business development conversations begin
↓
Licensing transaction
When independent inventors or academic labs attempt to out-license their IP, they frequently commit three fatal errors.
1. Pitching Legal Claims Instead of Business Value
Sending an 80-page patent document with 25 independent claims to a corporate Vice President of Engineering or Head of R&D is rarely an effective opening strategy.
Corporate executives generally evaluate:
- Gross margin expansion
- Throughput increases
- BOM (Bill of Materials) cost reduction
- Capital expenditure savings
- Time-to-market acceleration
- Regulatory advantages
They do not begin the conversation by reading dense patent claim language.
2. Demanding Upfront Non-Disclosure Agreements
Insisting that a prospective corporate partner sign a restrictive, bilateral NDA before revealing even the basic commercial problem the patent solves can create unnecessary friction.
Corporate legal teams are often cautious about signing unsolicited NDAs because doing so can create concerns around potential contamination of internal R&D projects with third-party intellectual property.
A better approach is to provide a concise, non-confidential summary first and introduce an NDA when the discussion moves into genuinely confidential technical or commercial information.
3. The "Cold Patent Threat" Stance
Framing outreach around potential infringement — for example, "We noticed your product X uses our patented method Y" — immediately shifts the conversation from a collaborative technology partnership to a defensive legal dispute.
The corporate legal team may then take control of the conversation rather than the R&D or business development team.
The objective should be to start with commercial value rather than an implied infringement claim.
1.2 The Mindset Shift: From Patent Owner to Strategic Solution Provider
To attract enterprise buyers, your outreach must lead with operational utility and quantifiable return on investment.
Enterprise corporations acquire or license external IP for several primary strategic reasons:
Accelerate R&D Time
Developing an unproven technology internally can require millions in capital and several years of engineering effort.
Licensing an already validated technology can potentially allow a company to accelerate commercialization.
Expand Gross Margins
A novel manufacturing method or chemical formulation that reduces unit manufacturing costs can directly improve product economics.
Protect Freedom to Operate
Securing appropriate licensing rights can reduce the risk that competitors obtain access to the same technology and create competitive disadvantages.
Address Regulatory and ESG Requirements
Patented technology that helps satisfy regulatory mandates — such as carbon reduction, PFAS elimination, or automotive safety requirements — can become strategically important.
2. Inside Corporate Technology Scouting: How Enterprises Buy IP
Understanding the internal hierarchy and decision-making dynamics of corporate business development and Open Innovation departments is critical to targeting the right decision-makers.
Corporate Technology Scouting Stakeholders
VP of Business Development / Corporate Strategy
Primary focus: Inorganic growth, M&A, and licensing pipelines
What triggers interest: Strategic market expansion and scalable revenue potential
Chief Technology Officer / VP of R&D
Primary focus: Technical feasibility and engineering integration
What triggers interest: Proven performance data and clean integration into the existing technology stack
Product Line General Manager / Business Unit Head
Primary focus: P&L performance, gross margins, and customer demand
What triggers interest: Immediate BOM cost reduction, customer demand, and a 6–12 month launch opportunity
Chief IP Counsel / Patent Business Development
Primary focus: Freedom to Operate, IP ownership, and litigation exposure
What triggers interest: Clean title, broad claim coverage, and minimal third-party encumbrances
2.1 The Open Innovation & External Technology Scouting Engine
Global corporations such as Siemens, Johnson & Johnson, 3M, Dow, Sony, and General Electric maintain dedicated Open Innovation and external technology scouting capabilities.
These professionals are tasked with identifying external laboratory breakthroughs, university disclosures, startups, and patent portfolios that solve predefined internal technology needs.
Scouts typically evaluate opportunities against structured technical criteria:
- Is the technology compatible with existing manufacturing lines or software runtimes?
- What is the current Technology Readiness Level (TRL)?
- Has the technology been validated in an operational environment?
- Is it currently at TRL 6–7, or is it still a theoretical proof of concept?
- Does the licensor have clean and unencumbered ownership?
- Are there disputed inventor claims?
- Are there government funding or march-in-right considerations?
2.2 Technology Readiness Levels: The Common Currency of Risk
When pitching to corporate R&D teams, framing your technology using the Technology Readiness Level (TRL 1–9) framework immediately provides a common language for assessing technical maturity.
TRL 1–3: Proof of Concept
Lab research, simulations, and basic technical validation.
Corporate appetite: Higher risk. Potential structures include sponsored research, development agreements, or option arrangements.
TRL 4–6: Validation in Relevant Environment
Working prototype, laboratory validation, and pilot-scale demonstration.
Corporate appetite: Often the sweet spot for technology partnering and licensing.
TRL 7–9: Operational System
Commercial-ready, production-tested, or regulatory-cleared technology.
Corporate appetite: Premium-value opportunities, including larger licensing transactions, OEM agreements, or acquisitions.
Platforms such as GoGetLicense can use TRL classifications to help technology owners present opportunities in a structured format for corporate technology scouts.
3. Building a High-Converting Patent Marketing Package
Before reaching out to prospective corporate licensees, assemble a professional Non-Confidential Marketing Package.
The Patent Marketing Arsenal
1. One-Page Non-Confidential Teaser
A concise executive summary explaining the technology and its commercial value.
2. Seven-Slide Commercial Pitch Deck
A focused presentation covering the problem, technology, performance, IP, integration requirements, and proposed transaction.
3. Proof of Performance
Supporting test data, demonstrations, videos, benchmarks, and validation results.
3.1 The One-Page Non-Confidential Executive Summary
The NCES is your primary door-opener.
It should be completely free of confidential trade secrets so corporate executives can circulate and evaluate it without unnecessary legal friction.
Key Elements of an Effective NCES
1. Compelling Value-Driven Headline
Instead of:
"US Patent 10,987,654: Improved Cathode Material"
Use:
"Patented Solid-State Cathode Coating that Increases EV Battery Energy Density by 34% at 15% Lower Cost."
2. Commercial Problem
Use 2–3 sentences to explain the exact manufacturing bottleneck, high cost, technical limitation, or market challenge.
3. Patented Solution
Provide a concise, high-level description of the proprietary mechanism or architecture.
4. Quantified Performance Benchmarks
Compare the patented technology against current industry benchmarks for:
- Speed
- Thermal limits
- Yield
- Energy consumption
- Weight
- Cost
5. Intellectual Property Status
Include:
- Patent numbers
- Jurisdictions
- Filing dates
- Priority dates
- Patent status
6. Technology Readiness Level
Clearly state the current prototype and validation stage.
7. Commercial Licensing Scope
Specify available structures such as:
- Exclusive licensing
- Non-exclusive licensing
- Field-of-use licensing
- Co-development
- Outright sale
8. Direct Contact Information
Provide the verified licensing officer, founder, technology transfer officer, or other appropriate contact.
3.2 The Seven-Slide Licensing Pitch Deck
When a corporate technology scout requests a discovery call, use a disciplined seven-slide presentation designed to move the conversation toward technical diligence.
Slide 1: Executive Overview
High-impact hook, technology name, and target application.
Slide 2: Industry Bottleneck
Explain why existing approaches face physical, regulatory, or economic limitations.
Slide 3: Breakthrough Technology
Explain how the patented architecture addresses the bottleneck.
Slide 4: Validated Performance
Present head-to-head performance graphs and benchmark data against incumbent solutions.
Slide 5: Global IP Footprint
Show granted patents, pending applications, continuations, and relevant IP positioning.
Slide 6: Commercial Integration & TRL Roadmap
Explain the time, capital, engineering resources, and infrastructure required for integration.
Slide 7: Licensing & Partnership Framework
Present potential transaction structures and proposed next steps.
4. Prospect Mining: How to Map the Corporate Buyer Matrix
Do not guess which companies might want your patent.
Use empirical patent data and corporate intelligence to construct a prioritized Corporate Buyer Matrix.
Buyer Identification Funnel
Forward Patent Citation Analysis
↓
Corporate R&D and Capex Analysis
↓
M&A and Licensing Track Record
↓
Technical Need Assessment
↓
Prioritized Buyer Matrix
↓
Tier 1 / Tier 2 / Tier 3 Targets
4.1 Forward Patent Citation Analysis
One of the strongest signals for identifying potential corporate buyers is forward patent citation analysis.
When an enterprise files a new patent application, the patent examiner may identify your issued patent as relevant prior art.
The resulting citation can provide an indication that the company's R&D organization is operating in a technology area related to your patent.
Why Citations Matter
If a Fortune 500 company has cited your patent multiple times across several patent families, it may indicate that its internal engineering teams are working in an adjacent technical field.
This does not automatically mean the company needs a license, but it can provide a useful signal for prioritizing business development outreach.
Tools for Citation Mining
Potential sources include:
- Google Patents
- Espacenet
- Lens.org
- USPTO patent databases
4.2 Analyzing Corporate Strategic Filings
For publicly traded corporations, analyze recent SEC Form 10-K filings and quarterly earnings call transcripts.
Item 1 — Business Overview
Look for strategic growth initiatives and new product launches.
Item 7 — Management's Discussion & Analysis
Look for:
- R&D expenditure trends
- Supply-chain challenges
- Manufacturing constraints
- Strategic investments
- New technology initiatives
Search for Key Triggers
Search transcripts and filings for terms such as:
- "Inorganic licensing"
- "Technology acquisition"
- "External innovation"
- "Supply chain constraints"
- "Strategic partnership"
- "Technology transfer"
Also search for specific technical keywords related to your patent claims.
4.3 Segmenting the Buyer Matrix
Tier 1: Global Market Leaders
Large-cap corporations with global reach.
Typical characteristics:
- Significant R&D budgets
- Established licensing teams
- Global commercialization capability
Typical deal appetite:
Exclusive worldwide licenses, large upfront payments, or IP acquisitions.
Typical decision speed:
Slow — often 9–18 months because of extensive technical, legal, and commercial diligence.
Tier 2: Fast Followers
Mid-market companies seeking differentiated technology.
Typical characteristics:
- Aggressive growth strategy
- Need for competitive differentiation
- Faster decision-making
Typical deal appetite:
Co-development, field-of-use exclusivity, and milestone-driven deals.
Typical decision speed:
Moderate — approximately 4–9 months.
Tier 3: Component Suppliers and OEMs
Direct manufacturers, component suppliers, and contract manufacturers.
Typical characteristics:
- Immediate manufacturing applications
- Strong focus on unit economics
- Direct connection to production
Typical deal appetite:
Non-exclusive manufacturing licenses and per-unit royalties.
Typical decision speed:
Potentially faster — approximately 3–6 months.
5. Out-Licensing Channels: Marketplaces, Direct Outreach, and Summits
Once your targets are identified, deploy a multi-channel distribution strategy.
Channel Comparison
Centralized IP Marketplaces
Discovery speed: Fast — days to weeks
Transaction cost: Can be zero commission depending on platform
Reach: Global corporate BD teams
Advantage: Structured discovery and continuous visibility
Traditional IP Brokers
Discovery speed: Slow — potentially months
Transaction cost: Often percentage-based commissions
Reach: Primarily broker network
Advantage: Hands-on transaction support
Pre-Conference Partnering Summits
Discovery speed: Medium to fast
Transaction cost: Event registration and travel costs
Reach: Highly targeted BD and innovation professionals
Advantage: High-quality face-to-face partnering opportunities
Cold Legal Letters
Discovery speed: Very slow
Transaction cost: Low direct monetary cost but potentially high legal risk
Reach: Very limited
Advantage: Generally poor as a first-line commercialization strategy
5.1 Centralized Digital IP Marketplaces: The GoGetLicense Advantage
Historically, patent out-licensing was throttled by fragmented discovery.
Technology transfer offices posted PDFs, independent inventors lacked effective distribution channels, and corporate scouting teams had to search hundreds of individual portals.
Centralized marketplaces such as GoGetLicense aim to reduce this discovery friction.
Searchable Global Listings
Corporate BD teams can discover in-licensing and out-licensing opportunities using structured information such as:
- Technology Readiness Level
- Patent number
- Publication DOI
- Technology category
- Target industry
Explore listings at GoGetLicense.
Direct Communication
A structured marketplace can connect corporate licensing teams, university technology transfer offices, researchers, and inventors directly.
Zero Transaction Fees
GoGetLicense is positioned as a zero-commission marketplace, allowing parties to connect without a percentage-based commission being deducted from the underlying licensing transaction.
5.2 Pre-Conference Partnering Directory Funnels
Major technology and innovation conferences such as AUTM, BIO International Convention, CES, Hannover Messe, and RSA Conference attract corporate licensing and Open Innovation professionals.
Instead of waiting for random booth visits, sophisticated out-licensors can prepare before the event.
Recommended Process
Step 1: Identify attending corporate sponsors, R&D executives, and technology scouts.
Step 2: Cross-reference those companies against your Corporate Buyer Matrix.
Step 3: Send your one-page Non-Confidential Teaser approximately 3–4 weeks before the conference.
Step 4: Pre-schedule targeted 30-minute partnering meetings.
5.3 Executing Multi-Touch Executive Outreach
When conducting direct outreach to corporate executives, use a multi-touch sequence combining LinkedIn, direct business email, and verified platform inquiries.
Example Outreach Email
Subject: [Quantified ROI] for [Company Name]'s [Product Category]
Hi [First Name],
I noticed your team's recent expansion in [Product Category/Initiative] and your ongoing work in [Technical Challenge].
We recently patented and validated a [TRL 5/6 Breakthrough] that delivers [Specific Performance Benchmark, e.g., 25% lower thermal load] without requiring changes to standard manufacturing tooling.
I've attached our one-page Non-Confidential Summary for your review:
Would you be open to a brief 15-minute introductory call next Tuesday to see if this aligns with your current R&D roadmap?
Best regards,
[Your Name]
[Title]
[Institution / Company]
6. Term Sheet Negotiations & Deal Structuring Playbook
When an enterprise buyer confirms technical interest, negotiations transition to commercial structuring.
Structuring a patent transaction requires balancing upfront cash, development risk, and long-term upside.
Core Deal Structures
Exclusive License
Sole commercial rights are granted to one licensee.
Typical characteristics:
- Higher upfront fee
- Development milestones
- Minimum annual royalties
- Strong commercialization obligations
Non-Exclusive License
Multiple companies can license the technology.
Typical applications:
- Platform technologies
- Manufacturing technologies
- Standards
- Software protocols
Field-of-Use License
The patent is divided into defined application areas.
For example:
- Company A — Automotive
- Company B — Aerospace
- Company C — Consumer Electronics
This can potentially maximize the total value of a versatile patent portfolio.
Outright Patent Assignment
The patent is sold outright for a lump-sum payment.
The buyer assumes ownership and the seller receives immediate consideration rather than ongoing royalties.
6.1 Core Transaction Frameworks
1. Exclusive Licensing
Grants the licensee sole commercial rights.
Licensors should consider substantial upfront fees, development milestones, and Minimum Annual Royalties (MARs)to discourage the licensee from shelving the technology.
2. Non-Exclusive Licensing
Allows multiple companies to implement the technology simultaneously.
This can work particularly well for broad platform technologies and manufacturing processes.
3. Field-of-Use Carveouts
One of the most powerful structures for versatile platform patents.
You may license:
Automotive → Company A
Aerospace → Company B
Consumer Electronics → Company C
while retaining rights for other fields.
4. Outright Patent Assignment
Provides a clean transfer of patent ownership for an immediate lump-sum payment.
This eliminates future royalty administration but also transfers future economic upside to the buyer.
6.2 Industry Royalty & Financial Benchmarks
Life Sciences & Therapeutics
Upfront fee: $100,000–$5,000,000+
Running royalty: 6%–14% of net sales
Typical milestones: IND filing, Phase 1/2/3 completion, regulatory approval
Potential MAR: $50,000–$500,000 per year
Medical Devices & Diagnostics
Upfront fee: $50,000–$500,000
Running royalty: 4%–8%
Typical milestones: 510(k) clearance, CE Mark, first commercial sale
Potential MAR: $25,000–$150,000 per year
CleanTech & Energy Storage
Upfront fee: $50,000–$350,000
Running royalty: 2.5%–6%
Typical milestones: Pilot validation and production scale-up
Potential MAR: $20,000–$100,000 per year
Automotive & Industrial Hardware
Upfront fee: $25,000–$250,000
Running royalty: 1.5%–4.5%
Typical milestones: OEM production approval and PPAP approval
Potential MAR: $15,000–$75,000 per year
Semiconductors & Optics
Upfront fee: $75,000–$1,000,000
Running royalty: 1%–3.5%
Typical milestones: Tape-out, wafer yield benchmarks, volume production
Potential MAR: $50,000–$250,000 per year
Enterprise Software & DeepTech Algorithms
Upfront fee: $20,000–$200,000
Running royalty: Tiered per-core pricing or percentage-based arrangements
Typical milestones: Production API integration and enterprise deployment
Potential MAR: $25,000–$150,000 per year
Important: Royalty rates vary substantially based on technology, patent strength, exclusivity, territory, remaining patent life, development risk, contribution of know-how, and expected commercial value. These figures should therefore be treated as illustrative benchmarks rather than universal market rates.
6.3 Essential Defensive Clauses for Licensors
Commercial Diligence Milestones
Require the licensee to hit specific technical or commercial milestones.
Examples:
- Prototype completion within 12 months
- Commercial launch within 24 months
- Minimum annual sales targets
Failure to meet agreed milestones can result in loss of exclusivity or conversion to a non-exclusive license.
Anti-Shelving & Minimum Royalties
If the licensee fails to generate sufficient sales, Minimum Annual Royalty provisions can protect the licensor from having the technology effectively shelved.
Audit Rights & Royalty Verification
The licensor should retain appropriate audit rights to verify royalty calculations and reported net sales.
Patent Prosecution & Maintenance
The agreement should clearly specify:
- Who pays patent maintenance fees
- Who controls prosecution
- Who handles patent enforcement
- Who pays enforcement costs
- How recoveries are allocated
7. The Step-by-Step 90-Day Out-Licensing Execution Roadmap
A disciplined 90-day sprint can help transform a passive patent portfolio into an active business development pipeline.
Days 1–15: IP Portfolio Audit & TRL Validation
- Confirm patent chain of title.
- Verify inventor assignments.
- Review patent status across relevant jurisdictions.
- Assess and document Technology Readiness Level.
- Gather supporting test data and validation reports.
Days 16–30: Marketing Asset Production
- Create the one-page Non-Confidential Executive Summary.
- Build the seven-slide commercial licensing pitch deck.
- Produce prototype demonstrations or videos where applicable.
- Prepare performance benchmark data.
Days 31–45: Citation Mining & Target Prospecting
- Extract forward and backward citations.
- Analyze USPTO and EPO patent databases.
- Identify corporate patent holders operating in adjacent technologies.
- Prioritize 20–30 corporate targets.
- Segment targets into Tier 1, Tier 2, and Tier 3.
- Identify relevant R&D, Open Innovation, licensing, and business development executives.
Days 46–60: Distribution & Marketplace Launch
- Publish a structured technology listing on GoGetLicense.
- Include TRL classifications and relevant patent information.
- Include DOI and publication references where applicable.
- Review upcoming industry partnering events.
- Launch the multi-touch outreach campaign.
Days 61–90: Diligence, Term Sheets & Closing
- Conduct introductory screening calls.
- Execute appropriate NDAs when confidential diligence begins.
- Provide technical diligence materials.
- Issue commercial term sheets.
- Negotiate milestones, royalties, exclusivity, and field-of-use provisions.
- Track negotiations through:
Pending → Replied → Negotiating → Agreed
Accelerate Your Patent Out-Licensing with GoGetLicense
Cold emailing corporate legal inboxes and waiting for patent scouts to discover your filings can waste valuable patent term and commercial opportunity.
GoGetLicense is a centralized B2B and academic marketplace connecting corporate R&D teams, university technology transfer offices, independent inventors, and research labs.
Search Global IP Opportunities
Explore in-licensing and out-licensing opportunities using structured information such as:
- Technology Readiness Level
- Patent number
- Publication DOI
- Technology category
- Industry
Interactive Deal Pipeline
Track negotiations through structured stages:
Pending → Replied → Negotiating → Agreed
Pre-Conference IP Discovery
Identify relevant corporate and research opportunities before major partnering events.
Zero Transaction Fees
GoGetLicense operates as a zero-commission connection platform for licensing and IP transfer opportunities.
👉 Create your verified company or researcher profile
Frequently Asked Questions
Why do enterprise corporations ignore unsolicited patent pitch emails?
Enterprise corporate counsel and R&D leaders are often cautious about unsolicited patent communications because of potential legal and intellectual property risks.
A better approach is to begin with a high-level, non-confidential commercial summary focused on product performance, cost savings, technology readiness, and strategic relevance.
What is a Non-Confidential Executive Summary?
A Non-Confidential Executive Summary (NCES) is typically a one- to two-page commercial teaser outlining:
- The technological problem
- The proposed solution
- Performance benchmarks
- Target market
- Technology Readiness Level
- Patent status
- Potential licensing opportunities
It should avoid confidential trade secrets and unnecessary technical disclosure.
How does patent forward-citation analysis help identify corporate buyers?
Forward-citation analysis examines which later patent applications cite your issued patent.
Repeated citations from the same company or corporate R&D group can indicate that the organization is actively developing technology in an adjacent area.
This makes the company a potentially interesting target for licensing discussions, although citation alone does not establish infringement or licensing need.
What is the typical royalty rate when out-licensing a patent?
Royalty rates vary widely depending on industry, patent strength, exclusivity, remaining patent term, commercial risk, and expected economic contribution.
Indicative ranges can be approximately:
- Industrial and automotive: 1.5%–5%
- Clean technology: 2.5%–6%
- Medical devices: 4%–8%
- Life sciences: 6%–14%+
These should be used only as starting points for valuation discussions rather than fixed market rates.
How does GoGetLicense help inventors and corporate out-licensors connect with buyers?
GoGetLicense provides a centralized B2B marketplace where patent owners, researchers, universities, and technology companies can present IP opportunities using structured information such as TRL, patent metadata, and publication references.
Corporate business development teams can discover relevant opportunities and connect directly with technology owners.
Strategic Takeaways & Commercialization Playbook
Successfully out-licensing patented technology to enterprise corporations is a systematic commercial process, not a lottery ticket.
1. Lead with Operational ROI, Not Legal Claims
Frame your patent around the business value it creates:
- Unit cost reduction
- Development speed
- Manufacturing efficiency
- Regulatory compliance
- Revenue growth
- Competitive differentiation
2. Do Not Demand Upfront NDAs for Basic Discovery
Use a polished one-page Non-Confidential Executive Summary to establish technical and commercial interest before introducing confidentiality agreements.
3. Mine Forward-Citation Data
Prioritize corporations whose patent portfolios demonstrate activity in technology areas adjacent to your invention.
4. Protect Your Upside with Rigorous Deal Covenants
Consider:
- Commercial milestones
- Minimum annual royalties
- Field-of-use restrictions
- Development obligations
- Audit rights
- Patent maintenance provisions
5. Leverage Centralized Digital Marketplaces
List your assets on GoGetLicense to create continuous exposure to corporate business development, R&D, technology scouting, and licensing teams.
Ready to Monetize Your Patent Portfolio?
Whether you are an independent inventor, university technology transfer office, startup, research laboratory, or corporate IP owner, the next step is to turn your patent portfolio into a structured commercial opportunity.
List your technology. Discover potential licensing partners. Build your out-licensing pipeline.
Comments
Post a Comment